<?xml version="1.0" ?>
<document id="30128822">
  <sentence id="30128822.s0" text="Machine learning search further revealed that the likelihood of signal transduction-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.">
    <entity charOffset="64-83" id="30128822.s0.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="100-106" id="30128822.s0.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="224-247" id="30128822.s0.e2" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="310-356" id="30128822.s0.e3" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="30128822.s0.e0" e2="30128822.s0.e1" id="30128822.s0.p0" relation="true"/>
    <pair e1="30128822.s0.e1" e2="30128822.s0.e3" id="30128822.s0.p1" relation="true"/>
    <pair e1="30128822.s0.e1" e2="30128822.s0.e2" id="30128822.s0.p2" relation="true"/>
  </sentence>
  <sentence id="30128822.s1" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="208-220" id="30128822.s1.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="244-269" id="30128822.s1.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="343-374" id="30128822.s1.e2" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="388-429" id="30128822.s1.e3" ontology_id="GO_2000300" text="regulation of synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="561-567" id="30128822.s1.e4" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="30128822.s1.e0" e2="30128822.s1.e4" id="30128822.s1.p0" relation="true"/>
    <pair e1="30128822.s1.e1" e2="30128822.s1.e4" id="30128822.s1.p1" relation="true"/>
    <pair e1="30128822.s1.e2" e2="30128822.s1.e4" id="30128822.s1.p2" relation="true"/>
    <pair e1="30128822.s1.e3" e2="30128822.s1.e4" id="30128822.s1.p3" relation="true"/>
  </sentence>
  <sentence id="30128822.s2" text="We found that both mRNA and protein levels of transcription by RNA polymerase II and its transcriptional activity were significantly higher in ER/PR -ve signal transduction +ve breast cancer samples compared to normal breast tissues.">
    <entity charOffset="46-80" id="30128822.s2.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="153-172" id="30128822.s2.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="184-190" id="30128822.s2.e2" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="30128822.s2.e0" e2="30128822.s2.e2" id="30128822.s2.p0" relation="true"/>
    <pair e1="30128822.s2.e1" e2="30128822.s2.e2" id="30128822.s2.p1" relation="true"/>
  </sentence>
  <sentence id="30128822.s3" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including positive regulation of protein phosphorylation, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="30128822.s3.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-148" id="30128822.s3.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="30128822.s3.e0" e2="30128822.s3.e1" id="30128822.s3.p0" relation="true"/>
  </sentence>
  <sentence id="30128822.s4" text="Promoters of several genes from the KEGG signal transduction+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the transcription by RNA polymerase II motif.">
    <entity charOffset="41-60" id="30128822.s4.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="69-75" id="30128822.s4.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-188" id="30128822.s4.e2" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="30128822.s4.e0" e2="30128822.s4.e1" id="30128822.s4.p0" relation="true"/>
    <pair e1="30128822.s4.e1" e2="30128822.s4.e2" id="30128822.s4.p1" relation="true"/>
  </sentence>
  <sentence id="30128822.s5" text="Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of transcription by RNA polymerase II as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer">
    <entity charOffset="128-162" id="30128822.s5.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="198-204" id="30128822.s5.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="30128822.s5.e0" e2="30128822.s5.e1" id="30128822.s5.p0" relation="true"/>
  </sentence>
</document>
